Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance

被引：19

作者：

Cham, Stephanie ^{[2
]}

Landrum, Mary Beth ^{[3
]}

Keating, Nancy L. ^{[3
,4
]}

Armstrong, Joanne ^{[5
]}

Wright, Alexi A. ^{[1
,6
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, 450 Brookline Ave, Boston, MA 02215 USA

[2] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, 75 Francis St, Boston, MA 02115 USA

[3] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA

[4] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA

[5] CVS Hlth, Womens Hlth & Genom, Hartford, CT USA

[6] Harvard Med Sch, Boston, MA 02115 USA

来源：

JAMA NETWORK OPEN | 2022年 / 5卷 / 01期

基金：

美国医疗保健研究与质量局;

关键词：

MUTATIONS;

D O I：

10.1001/jamanetworkopen.2021.42703

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cross-sectional study evaluates changes in the rate of germline BRCA testing among patients with ovarian cancer between 2008 and 2018 and analyzes factors associated with testing rates.

引用

页数：5

共 6 条

[1] Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population The ABOUT Study [J].

Armstrong, Joanne ;

Toscano, Michele ;

Kotchko, Nancy ;

Friedman, Sue ;

Schwartz, Marc D. ;

Virgo, Katherine S. ;

Lynch, Kristian ;

Andrews, James E. ;

Loi, Claudia X. Aguado ;

Bauer, Joseph E. ;

Casares, Carolina ;

Clark, Elizabeth Bourquardez ;

Kondoff, Matthew R. ;

Molina, Ashley D. ;

Abdollahian, Mehrnaz ;

Walker, Gregg ;

Sutphen, Rebecca .

JAMA ONCOLOGY, 2015, 1 (09) :1251-1260

[2]

Gondi S, 2019, AM J MANAG CARE, V25, P537

[3] Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients [J].

Kurian, Allison W. ;

Ward, Kevin C. ;

Howlader, Nadia ;

Deapen, Dennis ;

Hamilton, Ann S. ;

Mariotto, Angela ;

Miller, Daniel ;

Penberthy, Lynne S. ;

Katz, Steven J. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15) :1305-+

[4] Inherited Mutations in Women With Ovarian Carcinoma [J].

Norquist, Barbara M. ;

Harrell, Maria I. ;

Brady, Mark F. ;

Walsh, Tom ;

Lee, Ming K. ;

Gulsuner, Suleyman ;

Bernards, Sarah S. ;

Casadei, Silvia ;

Yi, Qian ;

Burger, Robert A. ;

Chan, John K. ;

Davidson, Susan A. ;

Mannel, Robert S. ;

DiSilvestro, Paul A. ;

Lankes, Heather A. ;

Ramirez, Nilsa C. ;

King, Mary Claire ;

Swisher, Elizabeth M. ;

Birrer, Michael J. .

JAMA ONCOLOGY, 2016, 2 (04) :482-490

[5] Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers [J].

Rebbeck, Timothy R. ;

Kauff, Noah D. ;

Domchek, Susan M. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (02) :80-87

[6] Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer [J].

Yang, Da ;

Khan, Sofia ;

Sun, Yan ;

Hess, Kenneth ;

Shmulevich, Ilya ;

Sood, Anil K. ;

Zhang, Wei .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (14) :1557-1565

← 1 →